急性失代偿性主动脉瓣狭窄的急诊治疗:紧急TAVI与紧急球囊成形术的比较
该多中心队列纳入23例紧急经导管主动脉瓣植入(eTAVI)和118例紧急球囊主动脉瓣成形术(eBAV)患者,比较两种急诊策略的早期结局。eTAVI组即刻手术死亡率为8.7%,eBAV组为20.3%(p=0.19);30天心血管死亡率分别为23.8%和33.0%(p=0.40),校正混杂因素后组间无差异证据。eTAVI组大血管并发症和卒中显著更多(p=0.01)。
要点
- 急诊TAVI与急诊球囊成形术的即刻和30天死亡率均较高,组间未显示显著差异。
- eTAVI组大血管并发症和卒中发生率显著高于eBAV组。
- eBAV后择期TAVI的死亡率高于预期,需随机研究明确急诊TAVI地位。
核心结论
- 在该多中心队列中,eTAVI与eBAV的即刻手术死亡率和30天死亡率均高,校正混杂因素后未提供组间差异证据。
- eBAV后择期TAVI的死亡率高于预期。
- 需要随机研究数据以明确当前器械时代急诊TAVI在三级医疗中心的作用。
研究设计与样本
- 多中心队列研究,在五家德国中心纳入23例接受eTAVI和118例接受eBAV的患者。
- 急诊条件定义为:需儿茶酚胺治疗的心源性休克、严重急性呼吸困难(NYHA IV)、心脏复苏或机械呼吸支持。
- 数据按VARC-2标准收集。
主要发现
- eTAVI组即刻手术死亡率为8.7%,eBAV组为20.3%(p=0.19)。
- eTAVI组30天心血管死亡率为23.8%,eBAV组为33.0%(p=0.40)。
- eBAV后择期TAVI(n=32)的即刻手术死亡率为9.4%,30天心血管死亡率为15.6%。
- eTAVI后大血管并发症(p=0.01)和卒中(p=0.01)显著更常见。
关键数值与推荐
- eTAVI组logistic Euroscore为37.7%±18.1,eBAV组为35.3%±20.8。
- eBAV后择期TAVI组logistic Euroscore为25.9%±13.9。
临床怎么用
- 对于急性失代偿性主动脉瓣狭窄,eTAVI和eBAV均可考虑但早期死亡率高,需权衡大血管并发症和卒中风险。
- eBAV后择期TAVI的死亡率高于预期,临床决策时应予以考虑。
局限性
- 为非随机多中心队列,样本量有限,可能存在混杂。
- 需要随机研究数据以明确急诊TAVI的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The optimal treatment of patients with acute and severe decompensation of aortic stenosis is unclear due to recent advances in transcatheter interventions and supportive therapies. Our aim was to assess the early outcome of emergency transcatheter aortic valve implantation (eTAVI) versus emergency balloon aortic valvuloplasty (eBAV) followed by TAVI under elective circumstances. METHODS: Emergency conditions were defined as: cardiogenic shock with requirement of catecholamine therapy, severe acute dyspnoea (NYHA IV), cardiac resuscitation or mechanic respiratory support. The data were collected according to the Valve Academic Research Consortium 2 (VARC-2) criteria. RESULTS: In five German centres, 23 patients (logistic Euroscore 37.7%±18.1) underwent eTAVI and 118 patients underwent eBAV (logistic Euroscore 35.3%±20.8). In the eTAVI group, immediate procedural mortality was 8.7%, compared with 20.3% for the eBAV group (p=0.19). After 30 days, cardiovascular mortality for the eTAVI group was 23.8% and for the eBAV group 33.0% (p=0.40). Analyses adjusting for potential confounders did not provide evidence of a difference between groups. Of note, the elective TAVI performed after eBAV (n=32, logistic Euroscore 25.9%±13.9) displayed an immediate procedural mortality of 9.4% and a cardiovascular mortality after 30 days of 15.6%. Major vascular complications were significantly more likely to occur after eTAVI (p=0.01) as well as stroke (p=0.01). CONCLUSION: In this multicentre cohort, immediate procedural and 30-day mortality of eTAVI and eBAV were high, and mortality of secondary TAVI subsequent to eBAV was higher than expected. Randomised study data are required to define the role of emergency TAVI in tertiary care centres with current device generations.
引用
- Bongiovanni D, Kühl C, Bleiziffer S, et al. Emergency treatment of decompensated aortic stenosis. Heart. 2017. PMID: 28566471. doi:10.1136/heartjnl-2016-311037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。